nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—CYP3A4—Thiotepa—sarcoma	0.262	0.405	CbGbCtD
Vilazodone—CYP3A4—Mitoxantrone—sarcoma	0.112	0.174	CbGbCtD
Vilazodone—CYP3A4—Vincristine—sarcoma	0.0774	0.12	CbGbCtD
Vilazodone—CYP2D6—Doxorubicin—sarcoma	0.0761	0.118	CbGbCtD
Vilazodone—CYP3A4—Etoposide—sarcoma	0.0709	0.11	CbGbCtD
Vilazodone—CYP3A4—Doxorubicin—sarcoma	0.0484	0.0748	CbGbCtD
Vilazodone—Cataract—Thiotepa—sarcoma	0.00856	0.0242	CcSEcCtD
Vilazodone—Hyponatraemia—Vincristine—sarcoma	0.00527	0.0149	CcSEcCtD
Vilazodone—Hyponatraemia—Mitoxantrone—sarcoma	0.00513	0.0145	CcSEcCtD
Vilazodone—Erectile dysfunction—Vincristine—sarcoma	0.00418	0.0118	CcSEcCtD
Vilazodone—Hallucination—Thiotepa—sarcoma	0.00407	0.0115	CcSEcCtD
Vilazodone—Erectile dysfunction—Mitoxantrone—sarcoma	0.00407	0.0115	CcSEcCtD
Vilazodone—Connective tissue disorder—Thiotepa—sarcoma	0.00402	0.0114	CcSEcCtD
Vilazodone—Eye disorder—Thiotepa—sarcoma	0.00382	0.0108	CcSEcCtD
Vilazodone—Cardiac disorder—Thiotepa—sarcoma	0.0038	0.0107	CcSEcCtD
Vilazodone—Ventricular extrasystoles—Epirubicin—sarcoma	0.00363	0.0103	CcSEcCtD
Vilazodone—Hallucination—Vincristine—sarcoma	0.00361	0.0102	CcSEcCtD
Vilazodone—Mental disorder—Thiotepa—sarcoma	0.00358	0.0101	CcSEcCtD
Vilazodone—Connective tissue disorder—Vincristine—sarcoma	0.00357	0.0101	CcSEcCtD
Vilazodone—Malnutrition—Thiotepa—sarcoma	0.00356	0.0101	CcSEcCtD
Vilazodone—Nervousness—Thiotepa—sarcoma	0.00346	0.00979	CcSEcCtD
Vilazodone—Cardiac disorder—Vincristine—sarcoma	0.00337	0.00953	CcSEcCtD
Vilazodone—Ventricular extrasystoles—Doxorubicin—sarcoma	0.00336	0.00951	CcSEcCtD
Vilazodone—Vision blurred—Thiotepa—sarcoma	0.00336	0.0095	CcSEcCtD
Vilazodone—Agitation—Thiotepa—sarcoma	0.00327	0.00926	CcSEcCtD
Vilazodone—Abnormal dreams—Epirubicin—sarcoma	0.00324	0.00917	CcSEcCtD
Vilazodone—Mental disorder—Vincristine—sarcoma	0.00318	0.00899	CcSEcCtD
Vilazodone—Convulsion—Thiotepa—sarcoma	0.00309	0.00873	CcSEcCtD
Vilazodone—Arthralgia—Thiotepa—sarcoma	0.00303	0.00858	CcSEcCtD
Vilazodone—Dry eye—Epirubicin—sarcoma	0.00303	0.00857	CcSEcCtD
Vilazodone—Dysgeusia—Mitoxantrone—sarcoma	0.00301	0.00852	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00301	0.00852	CcSEcCtD
Vilazodone—Abnormal dreams—Doxorubicin—sarcoma	0.003	0.00849	CcSEcCtD
Vilazodone—Agitation—Vincristine—sarcoma	0.0029	0.00821	CcSEcCtD
Vilazodone—Vision blurred—Mitoxantrone—sarcoma	0.0029	0.0082	CcSEcCtD
Vilazodone—Nervous system disorder—Thiotepa—sarcoma	0.00285	0.00806	CcSEcCtD
Vilazodone—Skin disorder—Thiotepa—sarcoma	0.00282	0.00799	CcSEcCtD
Vilazodone—Dry eye—Doxorubicin—sarcoma	0.0028	0.00793	CcSEcCtD
Vilazodone—Eye disorder—Etoposide—sarcoma	0.00275	0.00777	CcSEcCtD
Vilazodone—Convulsion—Vincristine—sarcoma	0.00274	0.00774	CcSEcCtD
Vilazodone—Cardiac disorder—Etoposide—sarcoma	0.00273	0.00772	CcSEcCtD
Vilazodone—Convulsion—Mitoxantrone—sarcoma	0.00267	0.00754	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00265	0.00749	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00263	0.00744	CcSEcCtD
Vilazodone—Arthralgia—Mitoxantrone—sarcoma	0.00262	0.00741	CcSEcCtD
Vilazodone—Paraesthesia—Thiotepa—sarcoma	0.00261	0.00738	CcSEcCtD
Vilazodone—Somnolence—Thiotepa—sarcoma	0.00258	0.00731	CcSEcCtD
Vilazodone—Dyspepsia—Thiotepa—sarcoma	0.00256	0.00724	CcSEcCtD
Vilazodone—Increased appetite—Epirubicin—sarcoma	0.00253	0.00717	CcSEcCtD
Vilazodone—Nervous system disorder—Vincristine—sarcoma	0.00253	0.00715	CcSEcCtD
Vilazodone—Decreased appetite—Thiotepa—sarcoma	0.00253	0.00715	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Thiotepa—sarcoma	0.00251	0.0071	CcSEcCtD
Vilazodone—Decreased appetite—Dactinomycin—sarcoma	0.00251	0.00709	CcSEcCtD
Vilazodone—Fatigue—Thiotepa—sarcoma	0.00251	0.00709	CcSEcCtD
Vilazodone—Dysgeusia—Etoposide—sarcoma	0.00251	0.00709	CcSEcCtD
Vilazodone—Hyperhidrosis—Vincristine—sarcoma	0.00249	0.00705	CcSEcCtD
Vilazodone—Fatigue—Dactinomycin—sarcoma	0.00249	0.00704	CcSEcCtD
Vilazodone—Skin disorder—Mitoxantrone—sarcoma	0.00244	0.0069	CcSEcCtD
Vilazodone—Hyperhidrosis—Mitoxantrone—sarcoma	0.00243	0.00687	CcSEcCtD
Vilazodone—Feeling abnormal—Thiotepa—sarcoma	0.0024	0.00678	CcSEcCtD
Vilazodone—Hyponatraemia—Epirubicin—sarcoma	0.00239	0.00676	CcSEcCtD
Vilazodone—Feeling abnormal—Dactinomycin—sarcoma	0.00238	0.00673	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Vincristine—sarcoma	0.00235	0.00664	CcSEcCtD
Vilazodone—Increased appetite—Doxorubicin—sarcoma	0.00235	0.00663	CcSEcCtD
Vilazodone—Migraine—Epirubicin—sarcoma	0.00234	0.00663	CcSEcCtD
Vilazodone—Insomnia—Vincristine—sarcoma	0.00233	0.0066	CcSEcCtD
Vilazodone—Paraesthesia—Vincristine—sarcoma	0.00231	0.00655	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00229	0.00647	CcSEcCtD
Vilazodone—Paraesthesia—Mitoxantrone—sarcoma	0.00225	0.00638	CcSEcCtD
Vilazodone—Decreased appetite—Vincristine—sarcoma	0.00224	0.00634	CcSEcCtD
Vilazodone—Somnolence—Mitoxantrone—sarcoma	0.00223	0.00631	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Vincristine—sarcoma	0.00223	0.0063	CcSEcCtD
Vilazodone—Fatigue—Vincristine—sarcoma	0.00222	0.00629	CcSEcCtD
Vilazodone—Convulsion—Etoposide—sarcoma	0.00222	0.00627	CcSEcCtD
Vilazodone—Hyponatraemia—Doxorubicin—sarcoma	0.00221	0.00626	CcSEcCtD
Vilazodone—Dyspepsia—Mitoxantrone—sarcoma	0.00221	0.00625	CcSEcCtD
Vilazodone—Decreased appetite—Mitoxantrone—sarcoma	0.00218	0.00617	CcSEcCtD
Vilazodone—Migraine—Doxorubicin—sarcoma	0.00217	0.00614	CcSEcCtD
Vilazodone—Fatigue—Mitoxantrone—sarcoma	0.00216	0.00612	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00216	0.00612	CcSEcCtD
Vilazodone—Breast disorder—Epirubicin—sarcoma	0.00215	0.00609	CcSEcCtD
Vilazodone—Asthenia—Thiotepa—sarcoma	0.00209	0.0059	CcSEcCtD
Vilazodone—Asthenia—Dactinomycin—sarcoma	0.00207	0.00586	CcSEcCtD
Vilazodone—Feeling abnormal—Mitoxantrone—sarcoma	0.00207	0.00585	CcSEcCtD
Vilazodone—Skin disorder—Etoposide—sarcoma	0.00203	0.00574	CcSEcCtD
Vilazodone—Hyperhidrosis—Etoposide—sarcoma	0.00202	0.00571	CcSEcCtD
Vilazodone—Breast disorder—Doxorubicin—sarcoma	0.00199	0.00563	CcSEcCtD
Vilazodone—Diarrhoea—Thiotepa—sarcoma	0.00199	0.00563	CcSEcCtD
Vilazodone—Diarrhoea—Dactinomycin—sarcoma	0.00197	0.00558	CcSEcCtD
Vilazodone—Dizziness—Thiotepa—sarcoma	0.00192	0.00544	CcSEcCtD
Vilazodone—Pollakiuria—Epirubicin—sarcoma	0.0019	0.00538	CcSEcCtD
Vilazodone—Paraesthesia—Etoposide—sarcoma	0.00188	0.0053	CcSEcCtD
Vilazodone—Somnolence—Etoposide—sarcoma	0.00186	0.00525	CcSEcCtD
Vilazodone—Asthenia—Vincristine—sarcoma	0.00185	0.00523	CcSEcCtD
Vilazodone—Vomiting—Thiotepa—sarcoma	0.00185	0.00523	CcSEcCtD
Vilazodone—Vomiting—Dactinomycin—sarcoma	0.00183	0.00519	CcSEcCtD
Vilazodone—Decreased appetite—Etoposide—sarcoma	0.00182	0.00513	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Etoposide—sarcoma	0.0018	0.0051	CcSEcCtD
Vilazodone—Asthenia—Mitoxantrone—sarcoma	0.0018	0.0051	CcSEcCtD
Vilazodone—Fatigue—Etoposide—sarcoma	0.0018	0.00509	CcSEcCtD
Vilazodone—Diarrhoea—Vincristine—sarcoma	0.00176	0.00499	CcSEcCtD
Vilazodone—Pollakiuria—Doxorubicin—sarcoma	0.00176	0.00498	CcSEcCtD
Vilazodone—Nausea—Thiotepa—sarcoma	0.00173	0.00488	CcSEcCtD
Vilazodone—Feeling abnormal—Etoposide—sarcoma	0.00172	0.00487	CcSEcCtD
Vilazodone—Diarrhoea—Mitoxantrone—sarcoma	0.00172	0.00486	CcSEcCtD
Vilazodone—Nausea—Dactinomycin—sarcoma	0.00171	0.00485	CcSEcCtD
Vilazodone—Dizziness—Vincristine—sarcoma	0.0017	0.00482	CcSEcCtD
Vilazodone—Vomiting—Vincristine—sarcoma	0.00164	0.00464	CcSEcCtD
Vilazodone—Connective tissue disorder—Epirubicin—sarcoma	0.00162	0.00458	CcSEcCtD
Vilazodone—Vomiting—Mitoxantrone—sarcoma	0.0016	0.00452	CcSEcCtD
Vilazodone—Eye disorder—Epirubicin—sarcoma	0.00154	0.00436	CcSEcCtD
Vilazodone—Nausea—Vincristine—sarcoma	0.00153	0.00433	CcSEcCtD
Vilazodone—Cardiac disorder—Epirubicin—sarcoma	0.00153	0.00433	CcSEcCtD
Vilazodone—Asthenia—Etoposide—sarcoma	0.0015	0.00424	CcSEcCtD
Vilazodone—Connective tissue disorder—Doxorubicin—sarcoma	0.0015	0.00424	CcSEcCtD
Vilazodone—Nausea—Mitoxantrone—sarcoma	0.00149	0.00422	CcSEcCtD
Vilazodone—Mental disorder—Epirubicin—sarcoma	0.00144	0.00408	CcSEcCtD
Vilazodone—Malnutrition—Epirubicin—sarcoma	0.00143	0.00406	CcSEcCtD
Vilazodone—Diarrhoea—Etoposide—sarcoma	0.00143	0.00404	CcSEcCtD
Vilazodone—Eye disorder—Doxorubicin—sarcoma	0.00142	0.00403	CcSEcCtD
Vilazodone—Cardiac disorder—Doxorubicin—sarcoma	0.00141	0.004	CcSEcCtD
Vilazodone—Flatulence—Epirubicin—sarcoma	0.00141	0.004	CcSEcCtD
Vilazodone—Dysgeusia—Epirubicin—sarcoma	0.0014	0.00397	CcSEcCtD
Vilazodone—Nervousness—Epirubicin—sarcoma	0.00139	0.00394	CcSEcCtD
Vilazodone—Dizziness—Etoposide—sarcoma	0.00138	0.00391	CcSEcCtD
Vilazodone—Vision blurred—Epirubicin—sarcoma	0.00135	0.00382	CcSEcCtD
Vilazodone—Mental disorder—Doxorubicin—sarcoma	0.00134	0.00378	CcSEcCtD
Vilazodone—Vomiting—Etoposide—sarcoma	0.00133	0.00376	CcSEcCtD
Vilazodone—Malnutrition—Doxorubicin—sarcoma	0.00133	0.00375	CcSEcCtD
Vilazodone—Agitation—Epirubicin—sarcoma	0.00132	0.00373	CcSEcCtD
Vilazodone—Flatulence—Doxorubicin—sarcoma	0.00131	0.0037	CcSEcCtD
Vilazodone—Dysgeusia—Doxorubicin—sarcoma	0.0013	0.00368	CcSEcCtD
Vilazodone—Nervousness—Doxorubicin—sarcoma	0.00129	0.00365	CcSEcCtD
Vilazodone—Palpitations—Epirubicin—sarcoma	0.00127	0.00359	CcSEcCtD
Vilazodone—Vision blurred—Doxorubicin—sarcoma	0.00125	0.00354	CcSEcCtD
Vilazodone—Convulsion—Epirubicin—sarcoma	0.00124	0.00352	CcSEcCtD
Vilazodone—Nausea—Etoposide—sarcoma	0.00124	0.00351	CcSEcCtD
Vilazodone—Arthralgia—Epirubicin—sarcoma	0.00122	0.00345	CcSEcCtD
Vilazodone—Agitation—Doxorubicin—sarcoma	0.00122	0.00345	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00121	0.00343	CcSEcCtD
Vilazodone—Dry mouth—Epirubicin—sarcoma	0.00119	0.00338	CcSEcCtD
Vilazodone—Palpitations—Doxorubicin—sarcoma	0.00117	0.00332	CcSEcCtD
Vilazodone—Convulsion—Doxorubicin—sarcoma	0.00115	0.00325	CcSEcCtD
Vilazodone—Nervous system disorder—Epirubicin—sarcoma	0.00115	0.00325	CcSEcCtD
Vilazodone—Skin disorder—Epirubicin—sarcoma	0.00114	0.00322	CcSEcCtD
Vilazodone—Hyperhidrosis—Epirubicin—sarcoma	0.00113	0.0032	CcSEcCtD
Vilazodone—Arthralgia—Doxorubicin—sarcoma	0.00113	0.0032	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00112	0.00317	CcSEcCtD
Vilazodone—Dry mouth—Doxorubicin—sarcoma	0.0011	0.00313	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00107	0.00302	CcSEcCtD
Vilazodone—Nervous system disorder—Doxorubicin—sarcoma	0.00106	0.003	CcSEcCtD
Vilazodone—Insomnia—Epirubicin—sarcoma	0.00106	0.00299	CcSEcCtD
Vilazodone—Skin disorder—Doxorubicin—sarcoma	0.00105	0.00298	CcSEcCtD
Vilazodone—Paraesthesia—Epirubicin—sarcoma	0.00105	0.00297	CcSEcCtD
Vilazodone—Hyperhidrosis—Doxorubicin—sarcoma	0.00105	0.00296	CcSEcCtD
Vilazodone—Somnolence—Epirubicin—sarcoma	0.00104	0.00294	CcSEcCtD
Vilazodone—Dyspepsia—Epirubicin—sarcoma	0.00103	0.00291	CcSEcCtD
Vilazodone—Decreased appetite—Epirubicin—sarcoma	0.00102	0.00288	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Epirubicin—sarcoma	0.00101	0.00286	CcSEcCtD
Vilazodone—Fatigue—Epirubicin—sarcoma	0.00101	0.00285	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000987	0.00279	CcSEcCtD
Vilazodone—Insomnia—Doxorubicin—sarcoma	0.00098	0.00277	CcSEcCtD
Vilazodone—Paraesthesia—Doxorubicin—sarcoma	0.000973	0.00275	CcSEcCtD
Vilazodone—Feeling abnormal—Epirubicin—sarcoma	0.000965	0.00273	CcSEcCtD
Vilazodone—Somnolence—Doxorubicin—sarcoma	0.000963	0.00272	CcSEcCtD
Vilazodone—Dyspepsia—Doxorubicin—sarcoma	0.000953	0.0027	CcSEcCtD
Vilazodone—Decreased appetite—Doxorubicin—sarcoma	0.000942	0.00266	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000935	0.00265	CcSEcCtD
Vilazodone—Fatigue—Doxorubicin—sarcoma	0.000934	0.00264	CcSEcCtD
Vilazodone—Feeling abnormal—Doxorubicin—sarcoma	0.000893	0.00252	CcSEcCtD
Vilazodone—Asthenia—Epirubicin—sarcoma	0.00084	0.00238	CcSEcCtD
Vilazodone—Diarrhoea—Epirubicin—sarcoma	0.000801	0.00227	CcSEcCtD
Vilazodone—Asthenia—Doxorubicin—sarcoma	0.000777	0.0022	CcSEcCtD
Vilazodone—Dizziness—Epirubicin—sarcoma	0.000774	0.00219	CcSEcCtD
Vilazodone—Vomiting—Epirubicin—sarcoma	0.000744	0.00211	CcSEcCtD
Vilazodone—Diarrhoea—Doxorubicin—sarcoma	0.000741	0.0021	CcSEcCtD
Vilazodone—Dizziness—Doxorubicin—sarcoma	0.000716	0.00203	CcSEcCtD
Vilazodone—Nausea—Epirubicin—sarcoma	0.000695	0.00197	CcSEcCtD
Vilazodone—Vomiting—Doxorubicin—sarcoma	0.000689	0.00195	CcSEcCtD
Vilazodone—Nausea—Doxorubicin—sarcoma	0.000643	0.00182	CcSEcCtD
